These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1226 related items for PubMed ID: 8913838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines.
    Pierré A, Léonce S, Pérez V, Atassi G.
    Cancer Chemother Pharmacol; 1998; 42(6):454-60. PubMed ID: 9788571
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
    Malonne H, Farinelle S, Decaestecker C, Gordower L, Fontaine J, Chaminade F, Saucier JM, Atassi G, Kiss R.
    Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Sep; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

  • 6. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G.
    Bull Cancer; 1993 Apr; 80(4):310-25. PubMed ID: 8173185
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The olivacine S16020 enhances the antitumor effect of ionizing radiation without increasing radio-induced mucositis.
    Maggiorella L, Frascogna V, Poullain MG, Berlion M, Lucas C, Razy SD, Eschwege F, Bourhis J.
    Clin Cancer Res; 2001 Jul; 7(7):2091-5. PubMed ID: 11448928
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS, Suh JM, Ahn SH, Kim JC, Yi JY, Hur KC, Hong WS, Muller MT, Chung IK.
    Cancer Chemother Pharmacol; 1998 Jul; 41(5):353-60. PubMed ID: 9523730
    [Abstract] [Full Text] [Related]

  • 13. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C, Barret JM, Kruczynski A, Perrin D, Hill BT.
    Invest New Drugs; 1998 Jul; 16(1):3-17. PubMed ID: 9740539
    [Abstract] [Full Text] [Related]

  • 14. Modulation of thiol pools by vitamin K3 and its effect on survival of sensitive and resistant murine tumor cells.
    Parekh H, Chavan S, Chitnis M.
    Anticancer Drugs; 1991 Apr; 2(2):159-68. PubMed ID: 1683589
    [Abstract] [Full Text] [Related]

  • 15. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
    Vanhuyse M, Kluza J, Tardy C, Otero G, Cuevas C, Bailly C, Lansiaux A.
    Cancer Lett; 2005 Apr 28; 221(2):165-75. PubMed ID: 15808402
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
    Kamath N, Grabowski D, Ford J, Ganapathi R.
    Br J Cancer; 1993 Jun 28; 67(6):1203-8. PubMed ID: 8099806
    [Abstract] [Full Text] [Related]

  • 18. In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts.
    Vassal G, Merlin JL, Terrier-Lacombe MJ, Grill J, Parker F, Sainte-Rose C, Aubert G, Morizet J, Sévenet N, Poullain MG, Lucas C, Kalifa C.
    Cancer Chemother Pharmacol; 2003 May 28; 51(5):385-94. PubMed ID: 12736760
    [Abstract] [Full Text] [Related]

  • 19. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K, Nakamura T, Ono M, Kusano T, Okada K, Kikuchi A, Adachi N, Kohno K, Higashi K, Kuwano M.
    Oncol Res; 1996 May 28; 8(5):197-206. PubMed ID: 8884812
    [Abstract] [Full Text] [Related]

  • 20. Multidrug-resistance circumvention and inhibition of [h-3] azidopine photolabeling of p-glycoprotein by new dihydropyridine derivatives displaying a low-affinity for calcium channels.
    Leonce S, Pierre A, Perez V, Guilbaud N, Krausberthier L, Genton A, Lombet A, Peglion J, Atassi G.
    Int J Oncol; 1994 Jun 28; 4(6):1243-50. PubMed ID: 21567044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.